Who is eligible for TRT in the UK?

The criteria

NHS provides TRT for men meeting specific criteria. The framework ensures appropriate use of healthcare resources.

Confirmed low testosterone

Multiple morning blood tests (typically two separate tests between 7 and 10 AM) showing total testosterone below 8 nmol/L (230 ng/dL). Borderline values between 8 and 12 nmol/L may qualify with strong clinical picture. Single low results do not meet criteria.

Clinical symptoms

Significant symptoms affecting quality of life. Persistent fatigue, reduced libido, erectile dysfunction, loss of muscle mass, mood changes. The symptoms must be substantial and persistent rather than mild or fluctuating. Symptoms alone are not sufficient. Numbers alone are not sufficient.

Other causes excluded

Investigation rules out other causes of symptoms (depression, sleep disorders, anaemia, thyroid disease, chronic illness). Additional hormonal testing (LH, FSH, SHBG, prolactin) identifies the underlying cause. Comprehensive assessment supports appropriate treatment decisions.

No contraindications

Absence of conditions that make TRT inappropriate. Prostate cancer requires specific assessment. Significant cardiovascular disease needs evaluation. Untreated severe sleep apnoea is concerning. The contraindications are not absolute but require careful management.

The straightforward cases

Some men clearly meet criteria for NHS TRT. These cases represent the most straightforward eligibility.

Primary hypogonadism

Confirmed testicular failure from injury, infection, surgical removal, chemotherapy, radiation or genetic conditions (Klinefelter syndrome). The condition typically produces clear low testosterone with high LH. Treatment is well established and uncontroversial.

Secondary hypogonadism

Pituitary tumours, head injury affecting hormonal regulation, certain pituitary disorders, opioid induced hypogonadism. The condition shows low testosterone with low LH. Treatment addresses the testosterone deficit while underlying causes may also need management.

Klinefelter syndrome

Genetic condition (XXY) producing testicular failure. Affects approximately 1 in 600 men. Often diagnosed during fertility investigation or for other reasons. TRT is standard treatment from diagnosis. NHS provision is clear cut for these patients.

Severe symptomatic hypogonadism

Very low testosterone (well below 8 nmol/L) with severe symptoms substantially affecting daily function. The clear clinical picture supports unambiguous treatment decisions. NHS access is generally straightforward for these cases.

The grey areas

Many cases sit in borderline territory where eligibility depends on clinical judgement. The complexity reflects real ambiguity rather than gatekeeping.

Borderline numbers with symptoms

Testosterone between 8 and 12 nmol/L with significant symptoms. Decision depends on symptom severity, free testosterone, exclusion of other causes and clinical judgement. Some men access NHS treatment in this range. Others need lifestyle approach first.

Age related decline

Older men with low testosterone matching expected age related decline plus modest symptoms. NHS access is more variable for these cases. Some areas treat aggressively, others conservatively. The decision involves judgement about benefit versus normal ageing.

Lifestyle related cases

Low testosterone with significant lifestyle contributors (obesity, sleep apnoea, chronic stress, heavy alcohol). NHS approach typically addresses lifestyle factors first. TRT may follow if lifestyle change does not resolve the issue. The sequential approach is standard.

Atypical presentations

Symptoms with normal testosterone, low testosterone without significant symptoms, complex multifactorial cases. These require specialist assessment to determine appropriate treatment. Endocrinology referral may be needed for complex cases.

Alternative access

Private clinics offer alternative TRT access. The eligibility criteria differ from NHS.

Easier criteria typically

Private clinics often treat borderline cases that NHS would not. Some treat based on symptoms alone with testosterone in the lower normal range. The easier access reflects different business models and approaches. Quality varies significantly between providers.

Reputable providers

Look for GMC registered doctors, proper blood testing protocols, ongoing monitoring, specialist support and transparent pricing. Quality clinics resemble medical practices. Avoid providers offering treatment without proper assessment or monitoring. The care quality matters.

Cost considerations

Private TRT typically costs hundreds to thousands of pounds annually. Initial assessment, ongoing monitoring, prescriptions all contribute. Compare comprehensive costs rather than initial fees alone. Long term commitment makes cost a significant factor.

NHS GP integration

Some men start private and transition to NHS care. Some maintain private throughout. Tell your NHS GP about private treatment. Communication between providers supports better care. Hiding private treatment creates risks.

Keep reading

For TRT basics, our Testosterone Replacement Therapy Explained covers the treatment. Testosterone Regulation and Prescribing Rules in the UK covers the legal framework. And What Is Considered Low Testosterone in the UK covers diagnostic thresholds.